Yes, I think most shareholders would agree, especially when the BORK climb towards $6 did not stabilize, to understand the business environment one enters.
I'm sure John Bourque initially saw Kryron as body armor, but soon after he realized two important aspects.
First, Obtaining revenue of magnitute in the armor arena wil be hard and slow with the established armor industry having the political might to step on us.
Second, Working with Kryron it soon became knowned that this alloy had great potential in non military applications, like the plasma spray applications to coat tools for farmers, and I know farmers, once in the field tending the dirt it either works or it doesn't, no politics involved.
The armor initiative should have been our long term goal, the plasma spray our first, and we would have obtained a revenue stream of cash a year ago, cash that actually would have advanced our armor progress farther than it is today.
KZMike's: This is what I know about other projects:
PLASMA SPRAY
The plasma spray 'opportunities' are taking longer than expected, NOT because of any problems or failures to garner business, but primarily due to a 'self imposed' testing process. Testing has been focused on 'testing to failure' and at this point 'failure has not been achieved'. . . It is critical to know where/how/when 'failure' occurs prior to marketing the product. However, with this product, IMO there comes a time when you drive a 'stake' in the ground and move forward and start marketing this, in the absence of other issues, and get sales/revenues in the pipeline.
News 
Market Data 
Discover 
